新闻
2023-05-19
Lucy Scientific Discovery Inc. Accelerates Psilocybin Access and Product Launch through a Strategic Partnership with TheraPsil
2023-05-19
Sania Therapeutics launches to advance novel medicines for neural circuit dysfunction
2023-05-19
Kapruvia® (difelikefalin) recommended by England’s NICE for the treatment of adults with moderate-to-severe CKD-associated pruritus
上市批准ASH会议临床结果
2023-05-19
Adverum Biotechnologies Introduces an Intravitreal Gene Therapy Program for Geographic Atrophy and Presents Data on Its Ocular Gene Therapy Platform
基因疗法
2023-05-19
礼来:PD-1激动剂抗体类风关二期临床成功
临床2期抗体药物偶联物
2023-05-19
卫材抗癫痫新药「吡仑帕奈口服混悬液」在中国获批
优先审批临床3期申请上市
2023-05-19
全球新药进展早知道05-19
临床研究临床申请申请上市
2023-05-18
Elevar Therapeutics Submits New Drug Application to FDA for Combination of Rivoceranib and Camrelizumab as First-Line Treatment Option for Unresectable Hepatocellular Carcinoma
临床结果孤儿药上市批准免疫疗法
2023-05-18
Ipsen to present new Bylvay® (odevixibat) data at annual ESPGHAN congress, showcasing commitment to furthering treatment for rare cholestatic liver diseases
临床结果并购上市批准
2023-05-18
Roche’s BTK inhibitor fenebrutinib significantly reduced brain lesions in people with relapsing forms of multiple sclerosis
临床结果临床3期